A Belgian court has ordered Poland and Romania to pay Pfizer Inc. €1.9 billion ($2.2 billion) for Covid-19 vaccines the countries refused to accept during the pandemic, marking a significant legal victory for the pharmaceutical giant. The ruling comes after both nations declined to take delivery of vaccine doses they had contracted to purchase, leaving Pfizer to pursue enforcement through international arbitration.

The dispute highlights the complex contractual obligations that arose during the global vaccine scramble, when governments raced to secure doses while managing uncertain demand and logistical challenges. Both Poland and Romania had initially negotiated contracts for millions of vaccine doses but later sought to reduce their orders or refuse delivery entirely as vaccination rates stabilized and pandemic conditions evolved.

This ruling sets an important precedent for pharmaceutical companies seeking to enforce vaccine contracts against governments that attempt to back out of agreements. The €1.9 billion judgment represents one of the largest vaccine-related contract disputes to date and may influence how future pandemic preparedness agreements are structured between drug makers and national governments.